计算溶液所需的质量、体积或浓度。
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
,适用于对基线干扰要求严格的色谱和分析工作流程。
-20°C储存。超低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 1 篇同行评审文献引用。
Trovafloxacin is a broad-spectrum quinolone antibiotic with potent activity against Gram-positive , Gram-negative and anaerobic organisms . Trovafloxacin blocks the DNA gyrase and topoisomerase IV activity. Trovafloxacin is also a potent, selective and orally active pannexin 1 channel (PANX1) inhibitor with an IC 50 of 4 μM for PANX1 inward current. Trovafloxacin does not inhibit connexin 43 gap junction or PANX2. Trovafloxacin leads to dysregulated fragmentation of apoptotic cells by inhibiting PANX1
In Vitro
Trovafloxacin (20 µM; 24 hours; HepG2 cells) and tumor necrosis factor (TNF; 4 ng/mL) incubation induces apoptosis and increases leakage of lactate dehydrogenase (LDH) in HepG2 cells. Trovafloxacin (20 µM; 24 hours; HepG2 cells) and TNF (4 ng/mL) incubation increases expression of early NF-κB-related factors A20 and IκBα. Trovafloxacin prolongs TNF-induced activation of MAPKs and IKKα/β activation in HepG2. Trovafloxacin is a potent inhibitor of TO-PRO-3 uptake by apoptotic cells. Trovafloxacin also inhibits ATP release from apoptotic cells. Trovafloxacin does not inhibit caspase 3/7 activation, or caspase-mediated PANX1 cleavage during apoptosis. Trovafloxacin is equally active against both penicillin-susceptible and -resistant pneumococci, with MICs of 0.06-0.25 mg/mL reported for more than 700 isolates. The MICs of Trovafloxacin at which 90% of isolates are inhibited for 55 isolates of pneumococci is 0.125 μg/mL. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Apoptosis AnalysisCell Line: HepG2 cells Concentration: 20 µM Incubation Time: 24 hours Result: Showed a gradual increase of Annexin V-staining and an increased leakage of lactate dehydrogenase (LDH) at 24 h. RT-PCRCell Line: HepG2 cells Concentration: 20 µM Incubation Time: 24 hours Result: Caused a higher increase in the transcription of A20 and IκBα in HepG2 cells.
In Vivo
Trovafloxacin (150 mg/kg; oral administration; male C57BL/6 J mice) treatment disrupts TNF-induced p65 nuclear translocation. Trovafloxacin treatment increases expression of early NF-κB-related factors A20 and IκBα . Trovafloxacin, when administered in combination with lipopolysaccharide (LPS) or TNF to mice induces severe liver toxicity associated with vast apoptotic areas in the liver, increased serum levels of alanine amino transferases (ALT) and pro-inflammatory cytokines . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male C57BL/6 J mice (9-11-week-old) injected with recombinant murine TNF ion Dosage: 150 mg/kg Administration: Oral administration Result: Showed a greater number of cells with increased nuclear/cytoplasmic p65 ratio in liver.
Form:Solid
IC50& Target:Quinolone
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机杂环化合物 |
| 类(Class) | 二氮杂萘 |
| 亚类(Subclass) | 萘啶类 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 萘啶羧酸及其衍生物 |
| 其他上位类(Alternative Parents) | 氟喹诺酮类药物 吡啶羧酸 二烷基芳胺 氨基哌啶类 氨基吡啶及其衍生物 氟苯类 芳基氟化物 咪唑内酰胺类 乙烯基酰胺 吡咯烷 杂芳族化合物 氨基酸 一元羧酸及其衍生物 氮杂环化合物 羧酸 碳氢化合物衍生物 单烷基胺 有机氧化物 有机氟化物 有机氧化合物 有机光子化合物 |
| 分子骨架(Molecular Framework) | 芳香族杂多环化合物 |
| 取代基(Substituents) | 4-氨基哌啶 - 氨基酸 - 氨基酸 - 氨基酸或其衍生物 - 氨基吡啶 - 芳香族杂多环化合物 - 芳基氟化物 - 芳基卤化物 - 氮杂环 - 苯基化合物 - 羧酰胺基 - 羧酸衍生物 - 二烷基芳基胺 - 氟萘 - 氟喹啉酮 - 卤苯 - 杂芳香族化合物 - 烃衍生物 - 咪唑内酰胺 - 单羧酸或其衍生物 - 单环苯基基团 - 萘噻吩羧酸 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机氟化物 - 有机卤化物 - 有机氮化合物 - 有机氧化合物 - 有机氮化合物 - 哌嗪 - 初级脂肪胺 - 初级胺 - 吡啶 - 吡啶羧酸 - 吡啶羧酸或其衍生物 - 吡咯烷 - 乙烯酰胺 |
| 描述(Description) | 该化合物属于萘啶羧酸及其衍生物类有机化合物。这类化合物含有萘啶结构单元,其中一个环原子带羧酸基团。 |
| 外部描述符(External Descriptors) | 暂无 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|